Articular cartilage destruction and loss of function in arthritic diseases involves proteolytic degradation of the connective tissue matrix. We have investigated the degradation of cartilage collagen by developing immunochemical methods that permit the identification and analysis of type II collagen degradation in situ. Previously, a technique to specifically identify type II collagen degradation in situ in articular cartilage did not exist. These methods utilize a polyclonal antiserum (R181) that specifically reacts with unwound a-chains and CNBr-derived peptides, al(II)CB11 and al(II)CB8, of human and bovine type II collagens. The experimental approach is based on the fact that when fibrillar collagens are cleaved the helical collagen molecule unwinds, exposing hidden epitopes. Here we demonstrate the use of R181 in studying type II collagen degradation in bovine articular cartilage that has been cultured with or without IL-1 and in human normal, rheumatoid, and osteoarthritic articular cartilages. Compared to cartilages either freshly isolated or cultured without IL-1, bovine cartilage cultured with IL-1 for 3-5 d showed an increase in both pericellular and intercellular immunohistochemical staining. Extracts of these cartilages contained type II collagen a chains that were increased in amount after culture with IL-1 for 11 d. In addition, culture with IL-1 resulted in the appearance of a chain fragments of lower molecular weight. All human arthritic tissues examined showed areas of pronounced pericellular and territorial staining for collagen degradation as compared with nondiseased tissues, indicating that chondrocytes are responsible in part for this degradation as compared with nondiseased tissues. In most cases rheumatoid cartilage was stained most intensely at the articular surface and in the deep and midzones, whereas osteoarthritic cartilage usually stained more in the superficial and mid-zones, but less intensely. Distinct patterns of sites of collagen degradation reflect differences in collagen destruction in these diseases, suggesting possible different sources of chondrocyte activation. These experiments demonstrate the application of immunological methods to detect collagen degradation and demonstrate an increase of collagen degradation in human arthritides and in IL-1-treated viable bovine cartilage.
Introduction
Most arthritic diseases result in the destruction of articular cartilage with a loss of function. The destruction is due, in part, to the degradation of the extracellular matrix, which is composed primarily of fibrillar type II collagen and aggregating proteoglycans. In articular cartilage, type II collagen fibrils are responsible for the tensile strength whereas the proteoglycans provide the compressive stiffness necessary for normal articulation and function (1) . The precise mechanisms by which these connective tissue components are degraded are not fully understood. In mammals, one mechanism involves collagenase, an enzyme capable of a site-specific cleavage of helical (native) collagen (2) . Incapable of maintaining a helical structure at physiological temperatures, collagenase-cleaved collagens unwind and become susceptible to further degradation by other proteinases in the extracellular space. In this regard, collagenase can be considered the rate limiting enzyme involved in collagen degradation. A variety of studies have provided indirect evidence that proteolytic enzymes are implicated in the destruction of articular cartilage, although there has been no direct evidence other than morphological (3, 4) that fibrillar collagen is being degraded at the tissue level, such as in cartilage. Limited proteolytic degradation of collagen in cartilage has been demonstrated to result in a loss of the tensile strength of cartilage with negligible release of collagen from the cartilage matrix, measured biochemically (5) .
Since the maintenance of tissue integrity is essential to normal function, factors that influence the synthesis, secretion, and activity of proteinases, such as collagenase, are important to examine. The cytokine, IL-1, has been shown to stimulate collagenase synthesis and secretion from a variety of cells including synovial cells, fibroblasts, and chondrocytes (6) (7) (8) . Even though IL-1 can be produced by different connective tissue cells and cells of the inflammatory response, its relationship to the pathogenesis of connective tissue diseases, such as rheumatoid and osteoarthritis, remains speculative. In vitro, stromelysin or neutral metalloproteinase has been shown to activate collagenase (9, 10) : it is also coordinately released with collagenase after stimulation with agents such as IL-1 or urate crystals (10) .
One major limitation on our ability to detect and study collagen degradation in health and disease has been the lack of a technique for identifying collagen breakdown in situ. We describe here both immunohistochemical and immunochemical methods that permit one to detect type II collagen degradation. These methods have been used to analyze collagen degradation in human and bovine articular cartilages. They employ an antibody (R181) that specifically reacts with fragmented and denatured human and bovine type II collagen a-chains and does not react with native helical collagens. Also, R181 does not react with bovine type V, VI, IX, and XI collagens, all of which are collagens found in cartilage matrix, nor with any other molecules in bovine and human cartilage extracts. The studies are based on the premise that when fibrillar collagens are cleaved by collagenase the subsequent unwinding and fragmentation results in the exposure of hidden epitopes that are not exposed in the native molecule. Earlier work (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] identified antibody reactive epitopes on unwound collagen a chains. These determinants are usually sequestered in the triple helix and are not detectable until this unwinds. Experimentally, an antibody that only recognizes epitopes on unwound or fragmented type II collagen, provides a tool to study cartilage collagen degradation as a normal function ofcartilage remodeling and in pathology. We report here experiments in which type II collagen degradation was demonstrated in situ and analyzed in explants ofbovine articular cartilage, cultured with IL-1, and in human articular cartilages from normal, rheumatoid, and osteoarthritic patients.
Methods
Tissue. Bovine condylar articular cartilage was obtained from animals (12-18 mo of age) from a local slaughterhouse shortly after sacrifice. For tissue culture studies, condylar cartilage was aseptically removed from the metacarpal-phalangeal joint. Bovine nasal cartilage and bovine skin were obtained from similar animals for the isolation and purification of types II and I collagen, respectively.
Human articular cartilages were obtained from the femoral condyles of adult knee joints with the following exceptions: radial head cartilage from patient K.E. (33-yr-old female, rheumatoid arthritic, rheumatoid factor negative); tibial plateau cartilage from patient C.P. (73-yr-old male, osteoarthritic). All arthritic cartilages were obtained at surgery from rheumatoid or osteoarthritic patients undergoing total joint arthroplasty or at the time of autopsy within 10 h postmortem. Four osteoarthritic cartilages were examined from patients P.S., 69-yrold male; V.M., 74-yr-old female; C.P., 73-yr-old male; C.R., 63- Nonarthritic (normal) cartilages were obtained from four individuals within 10 h postmortem at the time of autopsy, each having no known history nor signs ofarthritic/joint abnormalities. The following age-matched cartilages were examined: 73-yr-old male, 61-yr-old male, 56-yr-old male, and 17-yr-old female. All tissues were handled identically and processed for immunohistochemistry, as described below.
Collagen preparation. Type II collagen was extracted and purified from adult bovine nasal septum or adult human femoral condylar cartilage by differential salt precipitation as described by Miller (15) .
Briefly, the cartilage was minced with a scalpel and twice extracted with 4 M guanidine-HCI in 0.15 mM potassium acetate, pH 6.3 to remove the proteoglycan. The resulting residue was rinsed in water and dissolved in 0.5 M acetic acid containing 1 mg/ml pepsin (Cooper Biomedical, Malvern, PA) for 24 h at 4VC, with stirring. After centrifugation at 15,000 gav for 20 min the supernatant was adjusted to 0.9 M NaCl by slow addition of crystalline salt. The resultant precipitate was recovered by centrifugation and redissolved in 0.05 M Tris-HCI, pH 7.5 containing 1 M NaCl and dialyzed extensively against 0.02 M Na2HPO4. The precipitate was redissolved in 0.5 M acetic acid and NaCl was added to a final concentration of 2.22 M NaCl. The precipitated type IT collagen was collected by centrifugation and redissolved in 0.5 M acetic acid and exhaustively dialyzed against the same to remove residual NaCl. The collagen was then lyophilized, checked for purity by SDS-PAGE, as described below, and stored at -20'C.
Bovine type I collagen was isolated from bovine skin by differential salt precipitation as previously described ( 16 Density gradient centrifugation. Growth plate or adult, bovine or normal, human cartilage was dissected into small pieces of 1 mm3 and extracted with 4 M guanidine-HCI, 0.05 M EDTA, 0.15 M sodium acetate, pH 7.0, containing proteinase inhibitors as described for use in the immunohistochemical protocol. The extraction and subsequent fractionation were performed as described elsewhere (17) . The cesium chloride density gradient centrifugation was performed under associative conditions as described, resulting in fractions designated Al through A6 (nomenclature as described by Heinegird) (18) .
Cyanogen bromide cleavage ofcollagen. Collagens were cleaved at methionine residues with cyanogen bromide (CNBr) using a method based on others (19, 20) . Collagens were dissolved in 70% formic acid at a concentration of 5 mg/ml to which was added 12 mg/ml ofCNBr.
The tubes were flushed with nitrogen, sealed, and kept at 260C. To ensure the most complete cleavage possible, the reaction was continued for 18-20 h and was terminated by a 10-fold dilution with distilled water. After lyophilization the collagen peptides were stored at -20'C. Purity and characterization were determined by SDS-PAGE.
Antibody production. Female New Zealand white rabbits weighing 2.5 kg (Ferme des Chenes Bleues Inc., Montreal, Quebec) were maintained on rabbit chow (Ralston Purina Inc., Montreal, Quebec). Before immunization, serum was obtained from a preimmune blood sample of 30 ml taken under anesthesia using a combination ofketamine-HCl, (25 mg/kg; Rogar/STP, Inc., Montreal, Quebec) with xylazine (3 mg/kg Hauer-Lockhard; Bayvet Div., Miles Laboratories, Ltd., Rexdale, Ontario) by cardiac puncture.
For the antiserum, R18 1, the primary immunization, 5 mg bovine type II collagen CNBr-derived peptides in 0.5 ml 0.9% NaCl, 0.01% acetic acid was emulsified with 0.5 ml complete Freund's adjuvant (Difco, Detroit, MI). Half total volume was injected intramuscularly into each hind leg. Booster injections of I mg bovine type II CNBrpeptides emulsified with incomplete Freund's adjuvant (Difco) as before were injected either intramuscularly or subcutaneously or both, every 2-3 wk. Each booster was followed 2 wk later by a test bleed and antibody titer determination by ELISA.
After two booster injections the antiserum was of sufficient titer and 50 ml of blood were obtained by cardiac puncture. For immunohistochemical studies a F(ab')2 preparation was prepared by pepsin digestion, as previously described (21) . The Fc portion and undigested IgG were removed by absorption to AH-Sepharose-protein A (Pharmacia, Uppsala, Sweden) (22) . F(ab')2 was also prepared from normal rabbit serum and was used in immunohistochemical work as a control for the antiserum (R18 1).
Antisera R167 and R254 were prepared in this laboratory and used in these studies as a positive control for cartilage matrix components. For antiserum R167, the immunogen was fractions A4, 5, 6 of an associative cesium chloride density gradient centrifugation of bovine fetal growth plate cartilage (17) . To prepare antiserum R254, fractions A5 and A6 of a similar centrifugation gradient of bovine fetal growth plate were used to immunize the rabbit. Both antisera were prepared by a similar immunization protocol as described for R18 1, and were shown by ELISA to react with multiple proteins of whole-bovine cartilage extracts (Poole, A. R., unpublished observations).
The mouse monoclonal antibody AN9PI reacts with keratan sulfate when it is bound to cartilage proteoglycan core protein and has been described previously (23 15 min at room temperature the membrane was incubated for 1.5 h at room temperature with the antiserum (R18 1) or a mixture of antisera R254 and R167, or preimmune serum, each at 10% concentration after dilution in PBS containing 1% BSA. After exhaustive washing with PBS containing 0.01% Tween 20, the immunoblot was incubated for 1.5 h at room temperature with 125I protein A (Amersham Canada, Oakville, Ontario) (105 cpm/ml) in PBS containing 1% BSA. The membrane was then washed thoroughly in PBS, air dried and the radioactivity was visualized by radioautography using X-Omat AR x-ray film (Kodak, Rochester, NY). Routinely, the exposure time was overnight at -70°C with the use of a Cronex lightning plus intensifying screen (Dupont, Wilmington, DE).
Protein sequence analysis. CNBr-derived peptides of bovine type II collagen were electrophoresed in 1 mm thick 10% slab gels as described above. Separated proteins were electrophoretically transferred onto a polyvinylidine difluoride (PVDF)' membrane as described by Matsudaira for sequencing small quantities of proteins (28) . Briefly, the PVDF membrane is quickly stained with Coomassie Blue R250 after transfer and destained sufficiently to identify the protein bands. For the purposes of peptide identification, three major bands were cut out and their amino acid sequences determined by automated Edman degradation using a microsequencer (model 470A; Applied Biosystems, Foster City, CA). The derivatized amino acids were identified by on line high performance liquid chromatography using an analyzer, (model 120A; Applied Biosystems).
Bovine articular cartilage explant cultures. For culture of cartilage explants, serum-free Dulbecco's modified Eagle's medium (DME-B) (Flow Laboratories) was used with the following additions: BSA (crystallized), 0.1 mg/ml; gentamicin sulfate, 100 ,g/ml (both from Sigma);
1. Abbreviations used in this paper: APMA, 4-aminophenylmercuric acetate; PVDF, polyvinylidene difluoride. sodium pyruvate, 1 mM; nonessential amino acids, 0.1 mM (both from Gibco Laboratories, Grand Island, NY); 2-mercaptoethanol, 5 X 10-5 M. Bovine metacarpal cartilage was cut into small uniform pieces of -3 mm X 7 mm X 1 mm. Tissue was rinsed, first with BSA-free DME containing gentamicin at 200 Ag/ml and fungizone at 5 Ag/ml (Flow Laboratories), and then with regular BSA-free DME. Explants were randomly distributed into 12-well, 2.4 cm diameter, Linbro tissue culture plates (No. 76.053.05; Flow Laboratories) with each well containing 2 ml DMEM-B. Human recombinant IL-I13 (5 halfmaximal units/milliliter) (Cistron, Pine Brook, NJ) was added where indicated. Explants were maintained for up to 14 d at 370C in a humidified incubator containing 5% CO2 in air. Medium was changed every 2 d, with fresh addition of rIL-113 to the stimulated cultures. Tissues were removed at intervals, rinsed with PBS, and prepared for immunohistochemistry as described below. Culture media were stored at -20'C until assayed for collagenase activity.
In some experiments, an aliquot of the culture medium was examined for the presence of collagen. Media were concentrated using a Savant Speed Vac (Emerston Instruments, Scarborough, Ontario). The dried material was rehydrated in one tenth the original volume in SDS-PAGE sample buffer, electrophoresed (25 Al per track) and immunoblotted as described for antibody characterization. Antiserum R 18 1 was used to identify the presence ofcollagen on the immunoblot.
Cartilage extraction. Freshly isolated bovine articular cartilage, and cartilage cultured with or without IL-1, were subjected to extraction with 4 M guanidine HC1 in 0.15 mM potassium acetate, pH 6.3 including the proteinase inhibitors as described for use in the immunohistochemical protocol. Equivalent quantities (-25 mg) of cultured and noncultured cartilage were cut into small pieces of < 2 mm3 and extracted in 0.7 ml ofthe extraction solution, with rigorous shaking for 48 h at 4°C. The residual cartilage was removed by centrifugation for Collagenase assay. To measure collagenase activity, acid soluble guinea pig skin collagen was acetylated with [14C]acetic anhydride (10-30 mCi/mmol) generously provided by Dr. Elaine Golds (Joint Diseases Laboratory, Shriners Hospital for Crippled Children, Montreal, Quebec) and used in the standard fibril assay as described by Cawston and Barrett (29) . The assay was routinely performed for 18 h at 35°C in the presence of 4-aminophenylmercuric acetate 1 mM (APMA) to activate the latent enzyme. Test media were thawed before assay and centrifuged for 5 min using a fixed speed Eppendorf centrifuge 5313 (Fisher Canada) to remove any cells or debris.
Immunohistochemistry. Cartilage explants were mounted in OCT embedding media (Miles Laboratories, Naperville, IL), frozen and 6-Am thick sections were cut perpendicular to the articular surface at -20°C using a Tissue-Tek II cryostat (Miles Laboratories). Sections were picked up on glass microscope slides, precoated with a solution of 0.5% (wt/vol) gelatin in H20 containing 1 mM chromium potassium sulfate as described by Pappas (30) to enhance adherence of the tissue sections to the slide.
Sections were either immediately frozen and stored at -20°C or used immediately. Sections ofbovine tissue were fixed for 5 min in 4% formaldehyde freshly prepared from paraformaldehyde in PBS, pH 7.4 for 5 min (21), washed in PBS for 15 min and then for 15 min in 0.1% normal donkey serum (Serotec/Daymar Laboratories, Toronto, Ontario) in PBS, to block unreactive aldehyde groups for 15 min. These and subsequent manipulations were at room temperature. To enhance permeability of the tissue, sections were treated with chondroitinase ABC (Miles Laboratories) at 0.0 125 U/50 Al per section in Tris-acetate buffer, pH 7.6, for 90 min at 37°C in a humid environment to remove chondroitin sulfate (19) . Proteinase inhibitors included during enzyme treatment were: pepstatin (1 jg/ml), PMSF (I mM), iodoacetamide (1 mM), and EDTA (I mM). To examine bovine articular cartilage for Articular Cartilage Degradation 649 the accessibility of the antigen for antibodies (R181), full thickness pieces of normal bovine articular cartilage were incubated in DME with 0.125% (wt/vol) trypsin type XIII (No. T8642; Sigma), I mM EDTA, for 3 h at 370C. The enzyme activity was blocked by washing the tissue for 15 min with 1% normal donkey serum at room temperature. Frozen sections were prepared, fixed, and immunolocalization performed as described.
Sections of human cartilage were fixed for 8 min with 4% formaldehyde in PBS, pH 7.4, then washed and blocked in the same manner as described above for bovine tissue. Keratanase (Miles Laboratories) was added to the enzyme digestion solution for human tissue at 0.025 U/50 per section and the digestion was conducted for 18 h at 370C in a humidified chamber. After enzymatic pretreatment, all tissues were washed twice for 10 min with PBS containing 0.1% BSA.
Sections were incubated for 90 min at room temperature in a humidified chamber with 50 ul/section of R181 F(ab')2 or normal rabbit serum (NRS) F(ab')2 diluted in PBS containing 1% BSA including 0.25% vol/vol NP-40 (BDH Chemicals) at a concentration of 0.1 mg/ml. Controls were prepared by absorbing R181 F(ab')2 before use with 1 mg/ml of denatured type II collagen at 370 for 1 h followed by 18 h at 4VC and centrifugation before use to remove any precipitate. Sections were washed twice as above for 10 min after each antibody incubation. A biotin-streptavidin detection system (Amersham Corp., Arlington Heights, IL) was used consisting of a donkey F(ab')2 antirabbit Ig labeled with biotin, and either fluorescein-labeled streptavidin or gold (5-15 nM)-labeled streptavidin as the indicator. The biotinylated donkey anti-rabbit F(ab')2 was used at a dilution of 1/100 in PBS with 1% BSA at 50 ,l/section for 1 h. After washing twice, the sections were treated with 50 gl of the fluorescein-labeled streptavidin at a dilution of 1/50 in PBS with 1% BSA for 20 min at room temperature. After washing in PBS, the sections that were stained with fluoresceinlabeled streptavidin were counterstained with 0.001% (wt/vol) ethidium bromide in H20 for 1 min (to counterstain nuclei which fluoresce red) and mounted in -25 Ml ofa mixture ofTris-glycerol, pH 8.6 (31). Slides were examined for fluoresence immediately with incident illumination using a Zeiss photomicroscope III fitted with a 75-W xenon lamp. In studies where gold-labeled streptavidin was used, the silver enhancement method of Danscher and N6rgaard (32) , as modified by others (Lee, E., and A. R. Poole, manuscript in preparation), was utilized. Thus after sections were incubated with the biotinylated donkey anti-rabbit F(ab')2 and washed as described above, the sections were incubated with gold (5-15 nm)-labeled streptavidin at a dilution of 1/20 in PBS containing 1% BSA for 30 min at room temperature. After washing twice, the slides were dried slowly and held 4VC until next day, or when convenient, before proceeding. To proceed, the slides were dipped in a 0.5% gelatin in water and allowed to air dry. The physical developer was prepared by combining a 50% solution of gum arabic in water (BDH Chemicals, Montreal, Quebec), 6.67 ml citric buffer (2.0 M), 10 ml of 50 mM hydroquinone, and 10 ml of 40 mM silver lactate in the dark. The slides were dipped in this solution for I h at 30°C in the dark, after which the slides were flushed with tap water at -40°C for 30 min before exposure to light. The slides were then air dried and the sections mounted in Permount (Fisher Canada) . Using the light microscope the presence ofa positive reaction could be visualized as a black to brownish, grain-like staining.
In experiments where the murine monoclonal antibody, AN9PI was used the ascites fluid containing the antibody was diluted 1/32 in PBS containing 1% BSA and 0.25% vol/vol NP-40, as used for other antibodies. Normal ascites fluid (BRL) was used as a control diluted in the same manner. When AN9PI was used a second step antibody was needed in order to utilize the biotinylated-donkey anti-rabbit antibody. A rabbit antiserum to mouse IgG, prepared in this laboratory, was used at a dilution of 1/10 in PBS as described above. Reaction was visualized by silver enhancement of the gold-labeled streptavidin as described above.
Results

Characterization ofthe antibody
The reactivity of antibodies in antiserum RI 81 with different cartilage collagens was investigated by ELISA analyses (Fig. 1) . R181 reacted specifically with denatured (unwound) or CNBr-cleaved bovine type II collagen. Antibody reactions were assessed to CNBr-derived peptides of bovine type II collagen and native and denatured bovine collagen types II, V, VI, IX, XI (Fig. 1, a and b) . The strongest reactions were detected to the immunogen (type II CNBr-peptides) and to denatured type II collagen. A small reaction with native type II collagen was observed that probably resulted from the presence of a trace amount of denatured collagen in the type II preparation as a result of purification and handling. This was demonstrated by analysis of type II collagen by SDS-PAGE followed by transfer to nitrocellulose and immunostaining with antibody RI 81. At even low collagen concentrations, as shown in Fig. 2 , a small reaction with material of lower molecular weight was observed. This was not detectable by conventional Coomassie blue staining. There were no reactions with any other collagen tested. Preimmune R 181 exhibited no reaction with any of the collagens tested ( Fig. 1 a and b) . The reactivity of antiserum RI 81 with human type II collagen was also determined by ELISA (Fig. 3) . Native, denatured, and CNBr-derived peptides of human type II collagen were examined and compared in their reactivity to bovine type II collagen CNBr-derived peptides. Equivalent reactions were seen to human and bovine type II CNBr-derived collagen peptides and denatured type II collagen, whereas in this case there was no reaction with native human type II collagen over and above that shown by preimmune serum, which showed no reaction with any of the other collagens tested.
To characterize further the specificity of Ri 81, purified type I and type II collagens, type II CNBr peptides and whole cartilage extract and fractions thereof separated by cesium chloride density gradient centrifugation, were electrophoresed in a 10% SDS-polyacrylamide gel under reducing conditions, and the separated proteins were then electrophoretically transferred onto nitrocellulose. The transblot was either incubated with preimmune, immune RI 81 serum or a mixture of R254 and R167, each at a dilution of 10%. As seen in Fig. 4 a, preimmune RI 81 showed no reactivity to any of the proteins examined, whereas immune serum Ri81 (Fig. 4 b) reacted with purified, denatured bovine a(II) chains, and peptides of bovine type II collagen. No reaction was detected with purified bovine type I collagen, nor with any proteins found in the bovine cartilage extract except for a weak band of reactivity detected in fraction 6 of the cesium chloride density gradient, corresponding in size to the a I (11) chains. To demonstrate the presence of other cartilage proteins on the transblot which were unreactive with RI 81, we incubated the same transblot with a mixture of two antisera designated RI 67 and R254. As can be seen in Fig. 4 c, these antisera react with a wide variety of proteins that are present on the nitrocellulose, none of which react with R1 81 except type II collagen a chains. CNBr-derived peptides of type II collagen, which have epitopes reactive with RI 81 were identified by their relative molecular sizes using SDS-PAGE analyses and by microsequencing of these electrophoretically separated peptides. In Fig. 4 b the major antibody reactive peptides were identified as a l (II)CB8 and a l (II)CB 1. This identification was made possible by comparing a Coomassie blue stained lane of electrophoresed CNBr-derived peptides of a I (11) to an immunoblot of the same stained with the antiserum R 181 (Fig. 5) . Peptides a l(II)CB8, 10,11 were conclusively identified by sequencing the first 10-20 amino acids of the peptides obtained from an identical SDS-PAGE as shown in Fig. 5 and comparing the amino acid sequences with those which have been published (33) (Fig. 6) . Two Ri81 reactive bands, (al(II)CB8 and a I(II)CB 11 were identified by amino acid sequencing and a major band, as seen by Coomassie blue staining, was identified by amino acid sequence as a l (II)CB 10. This peptide was clearly unreactive with the antiserum RI 81 (Fig. 5) . Based on previous studies of CNBr-derived peptides of type II collagen (34) , the largest peptide is a 1 (II)CB 10. Therefore any peptide species larger than a l(II)CB 10 results from incomplete cleavage at methionine residues or the presence of nonreducible crosslinks.
These data demonstrate the specificity of RI 81 for denatured bovine and human type II collagen and two CNBr-derived peptides of type II collagen. The two major reactive peptides are located well within the helical region of the alpha chain in the NH2-terminal half of the molecule. Fig. 7 IL-1.
with NRS F(ab')2 did not stain. Only the cell nuclei were visible due to the counterstain, ethidium bromide (Fig. 10 a) .
When R181 F(ab')2 was preabsorbed with denatured type II collagen before use, staining was considerably reduced demonstrating removal of antibodies to denatured type II collagen a chains.
Sections of bovine articular cartilage that were pretreated with trypsin to remove proteoglycan were stained with R181 in an identical manner with no increase in staining in both those sections from cartilage treated with or without trypsin. Staining with antibody AN9P1 to keratan sulfate of trypsintreated cartilage was significantly reduced as compared to that observed in nontrypsin treated cartilage. Similar sections of cartilage were stained with toluidine blue and showed a near complete removal of glycosaminoglycans after trypsin pretreatment (data not shown). These observations provide further evidence that there is no masking of collagen epitopes by proteoglycans and that enhanced staining seen with R181 is not due to increased antibody accessibility, nor is it reactive with exposed helical collagen.
When cryosections of articular cartilage cultured for 5 d with IL-1 were examined (Fig. 10 d) , intense green staining with R181 was observed both in pericellular regions and throughout the matrix as compared with cartilage cultured for the same time without IL-I (Fig. 10 c) , or control cartilage that was not cultured (Fig. 10 b) (Fig. 10 b) . In general, the articular surface was lightly stained in all cartilages. This staining showed some increase with culture time and/or the presence of IL-1. The cut edges in uncultured cartilage were not usually stained, whereas after culture the cut edges stained brightly with R 181.
To further control the various steps in the staining protocol, sections were also incubated without the primary antibody F(ab')2 and with the appropriate dilution of biotinylated donkey anti-rabbit or fluorescein-labeled streptavidin. Cartilage sections were not stained when treated with these reagents separately or together (data not shown).
Immunochemical analysis of extracts of bovine cartilage explants and ofculture mediafor the presence ofcollagen type II degradation products. As a corollary to the in situ detection and demonstration of collagen degradation, we investigated whether or not collagen a chains or fragments thereofcould be detected in culture media and cartilage extracts. Media were removed from explant cultures treated with or without IL-I at days 5, 9, and 11 and examined by immunoblotting with R18 1. There was no evidence of reactivity with R181 with any protein, smaller than the intact alpha chain of type II collagen from the medium taken at days 5, 9, or 11 from either IL-I treated tissue or control tissue not treated with IL-1, except in one experiment where a fragment of low molecular weight (15 kD) was detected (data not shown). Therefore, fragments of collagen-bearing immunoreactive epitopes are not ordinarily present in sufficient quantities in the culture media to be detected by this methodology.
In contrast, extracts of cartilage cultured with IL-I for 11 d contained an immunoreactive band of a slightly smaller size than an intact a chain that was not detectable in extracts from cultured cartilage without IL-1 after identical periods, or from normal, uncultured bovine cartilage (Fig. II b) . The larger band could correspond to a cleaved or partially degraded a chain initiated by collagenase cleavage (33) . This remains to be established. An additional smaller band migrating near the 30-kD globular standard was observed in extracts from cartilage cultured for 11 d with IL-1. This could represent a product of further proteinase action on the a chain, particularly since the R181-reactive epitopes of this fragment are located upstream from the mammalian collagenase cleavage site. These R18 1-reactive bands were not seen in the control immunoblot which was incubated with preimmune serum (Fig. 11 a) . Intact type II collagen was extractable from cartilage treated with or without IL-I at each time point, although more was extracted from cartilage of 1 l-d-old cultures incubated with IL-1.
Immunohistochemical identification ofcollagen degradation in human normal, osteoarthritic, and rheumatoid arthritic articular cartilages Human normal cartilages from healthy joints, osteoarthritic and rheumatoid arthritic articular cartilages were examined for type IT collagen degradation using antiserum R181. Patients were undergoing total knee arthroplasty. Normal cartilage was obtained at the time of autopsy within 10 h of death. Each arthritic patient was diagnosed as having advanced forms of osteoarthritis or rheumatoid arthritis and are discussed in Methods. In the case of osteoarthritic cartilages, histological examination of the cartilage confirmed the diagnosis: gross irregularities in the articular surface were seen with fibrillation.
In the example shown (patient P.S.), the most striking staining was throughout the regions of the superficial fibrillation (Fig.  12 b) and in the interterritorial matrix in the superficial and mid-zones (Fig. 12 d) . The NRS F(ab')2 incubated tissue did not stain (Fig. 12 a) . Evidence of pericellular degradation was also seen in the deep zone (Fig. 12 f) , although this was restricted in this example, to the pericellular areas of the deep zone chondrocytes with little or no intercellular matrix staining elsewhere in this zone. These areas were not stained with the control NRS F(ab')2. Three of four osteoarthritic cartilages examined showed this pattern of staining, while cartilage from patient CR was stained with RI throughout the superficial zone) and heavily stained in terr- amined. Shown in Fig. 13 is a photomicrograph of articular torial sites around the chondrocytes in the deep zone.
cartilage from patient A.D. stained with RI 81 F(ab')2 ( Fig. 13 Intense pericellular, territorial and interterritorial matrix b) and control NRS F(ab')2 (Fig. 13 a) . In (Fig. 13,aandc) . We examined four nonarthritic (normal) cartilages, all of which exhibited weak staining ofthe articular surface (some of which was also seen in controls treated with NRS F(ab')2. There was limited pericellular staining observed at all levels (Fig. 14) .
As a control for accessibility of antibody Rl8 1 in cartilage, human rheumatoid articular cartilage (patient A.D.) was stained for proteoglycan using the monoclonal antibody AN9Pl and its staining pattern compared to that of R181.
Cartilage sections incubated with AN9P1 were intensely stained throughout the superficial, mid, and deep zones in a uniform pattern. Less staining for proteoglycan was observed in the superficial matrix than elsewhere. In comparison, the staining pattern seen with R181 was as previously described, concentrated at the articular surface and in the pericellular and territorial areas of the deep zone (data not shown). Therefore there is again no evidence to indicate that increased staining with Rl8 1 could be due to an increased accessibility of antibody as a result of a local loss of proteoglycan.
Discussion
One ofthe limiting factors in the study ofcartilage degradation has been the inability to detect collagen breakdown in articular cartilage other than by detecting the release of hydroxyproline (36) . By using a highly specific polyclonal antibody directed against fragmented and denatured type II collagen, we have developed methods for the detection of collagen degradation in situ produced both experimentally and in human arthritis. Based on earlier work on the immunology and antigenicity of collagens (13, 14, (Fig. 7) , where the initial disruption of the collagen molecule is thought to occur. The higher molecular weight fragment of type II collagen a chain identified in extracts of bovine cartilage undergoing collagen degradation induced by IL-1 which is similar in size to the three-fourths length collagenase cleavage product (35) In the human cartilages examined, differences in staining of degraded collagen were not only in intensity, but also in distribution. In three of the four osteoarthritic cartilages examined, staining was observed mainly in the superficial and midzones, often where fibrillation is occurring, with intense staining in both pericellular sites and moderate staining in territorial sites that may vary in location depending upon the joint pathology of each patient. The pericellular and strong diffuse staining associated with fibrillated superficial cartilage clearly indicates collagen degradation in these sites and explains in part the appearance of fibrillated cartilage.
In contrast, in rheumatoid cartilages there was very intense staining of the articular surface. This collagen degradation may be caused by proteolytic enzymes originating from the synovial fluid which are capable of degrading collagen. Obvious candidates are the collagen-degrading proteases, elastase and cathepsin G (40, 42), which can be released by polymorphonuclear leukocytes upon attachment to articular cartilage which results in the degradation of the more superficial articular cartilage (43, 44) . In one specimen (K.E.), degradation was detected throughout the matrix. In the others it was concentrated in the deep and mid-zones. Degraded type II collagen was detected around chondrocytes in pericellular and territorial sites in the deep zone close to the calcified cartilage. Most rheumatoid cartilage was examined from sites at or close to the cartilage-synovial junction. The data indicate that not only may type II collagen degradation occur at the cartilage-synovial junction, associated with mononuclear cell infiltration and pannus formation (3, (45) (46) (47) , but that it also occurs around the chondrocytes more remote from the articular surface and remote from the synovium and synovial fluid. Earlier, ultramorphological studies of rheumatoid articular cartilage, using cationic dyes, also showed that proteoglycans were lost and collagen was damaged in the deep zone cartilage (4). Since much of the degradation in human cartilage was centered around cells, the chondrocyte is clearly implicated as the primary source of enzymes degrading the type II collagen, as in bovine cartilage.
We have shown in bovine cartilage that molecules such as IL-1 can diffuse into bovine cartilage and activate chondrocytes to degrade the collagen matrix throughout the matrix. The degradation of collagen around and between cells appear to result from chondrocyte activation resulting from cytokines, such as IL-1. In addition to such cytokines originating from synovium, pannus, and synovial fluid (48), they could also arise from the inflamed subchondral bone marrow. Inflammatory changes are well recognized in subchondral sites in rheumatoid arthritis and are associated with bone resorption and loss which can result from the action of cytokines such as IL-1 and tumor necrosis factor (49-53). Cellular infiltration from subchondral bone into cartilage has also been observed in rheumatoid arthritis (54) (55) (56) . Earlier studies by Fell and co-workers demonstrated that stimulation of subchondral bone marrow with complement sufficient antiserum can cause degradation of the adjacent articular cartilage (57, 58 (59, 60) . Moreover, denatured type II collagen injected into rats and mice can elicit the development of erosive inflammatory joint disease resembling rheumatoid arthritis (48, 61, 62) . This involves the expression of T cell mediated immunity to the collagen as well as antibody production. Injection of T cell clones that recognize both helical and denatured type II collagen can induce a rheumatoid-like polyarthritis (63) . T cell mediated autoimmunity to type II collagen, in particular to the degraded molecule could therefore arise in patients with rheumatoid arthritis as a result of the release of immunologically active collagen fragments produced by collagen degradation and may play a pivotal role in the immunopathology of these diseases.
There is a large body of evidence that would link both collagen and proteoglycan-degrading enzymes to the loss of integrity of articular cartilage in arthritic diseases (48) . The study described here has permitted the identification of cartilage collagen degradation in experimental and human pathology and has produced important observations and raised questions concerning the pathology of these diseases. Further studies utilizing these techniques should help to elucidate the destructive process involved and the mediators that regulate the control of cartilage destruction.
